Thus, the 3 hub effective components (luteolin, kaempferol, and quercetin) and 8 targets (VEGF, CASP3, JUN, TP53, AKT1, IL6, TNF, and MMP9) might play essential roles in the treatment of pneumonia by YHPGKL. This evidence concerns the gene CASP3 and susceptibility to pneumonia measurement.